Company Name : Memphis Pharmaceuticals ISIN Code : EGS38351C010 Reuters Code : MPCI.CA Content : Central Auditing Organization's report on the financial statements for the financial period ending 31/12/2025 The Central Auditing Organization's Report (508 KB) The Central Auditing Organization's Report (508 KB)